WELTERS ANTHONY (CIK 1213307) reported 12 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-08-27). Recent activity: Buy GILD (7,718 shares), Sell GILD (3,118 shares), Sell GILD (4,600 shares), Buy GILD (10,282 shares), Sell GILD (3,402 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-27 | GILEAD SCIENCES, INC. (GILD) | Director | Buy | 7,718 | $468,251 |
| 2026-08-27 | GILEAD SCIENCES, INC. (GILD) | Director | Sell | 3,118 | $462,432 |
| 2026-08-27 | GILEAD SCIENCES, INC. (GILD) | Director | Sell | 4,600 | $684,590 |
| 2026-08-27 | GILEAD SCIENCES, INC. (GILD) | Director | Buy | 10,282 | $630,801 |
| 2026-08-27 | GILEAD SCIENCES, INC. (GILD) | Director | Sell | 3,402 | $504,296 |
| 2026-08-27 | GILEAD SCIENCES, INC. (GILD) | Director | Sell | 6,880 | $1.0M |
| 2026-05-04 | GILEAD SCIENCES, INC. (GILD) | Director | Buy | 1,146 | $0 |
| 2026-05-01 | Carlyle Group Inc. (CG) | Director | Buy | 4,450 | $0 |
| 2025-11-25 | Carlyle Group Inc. (CG) | Director | Sell | 11,706 | $0 |
| 2025-11-25 | Carlyle Group Inc. (CG) | Director | Sell | 1,200 | $0 |
| 2025-05-08 | GILEAD SCIENCES, INC. (GILD) | Director | Buy | 1,516 | $0 |
| 2025-05-02 | Carlyle Group Inc. (CG) | Director | Buy | 5,235 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-08-27